To Assess the Safety and Efficacy of R932348 Ophthalmic Solutions in Patients With Keratoconjunctivitis Sicca
Status:
Completed
Trial end date:
2014-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether 0.2% and 0.5% R348 Ophthalmic Solutions are
safe and effective in the treatment of Patients with Keratoconjunctivitis Sicca.